Kingworld Medicines Group Limited (HKG:1110)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.4800
0.00 (0.00%)
Apr 2, 2026, 3:11 PM HKT

Kingworld Medicines Group Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
283307270392529473
Market Cap Growth
20.80%13.61%-31.19%-25.88%11.84%1.33%
Enterprise Value
539594465522655601
Last Close Price
0.480.520.430.560.740.62
PE Ratio
22.4724.426.109.3420.5812.71
Forward PE
-9.169.169.169.169.16
PS Ratio
0.280.300.240.330.490.46
PB Ratio
0.370.400.360.510.670.54
P/TBV Ratio
0.480.520.460.670.890.75
P/FCF Ratio
--2.68-5.0316.85
P/OCF Ratio
--1.878.422.514.75
EV/Sales Ratio
0.530.580.410.440.610.58
EV/EBITDA Ratio
5.737.004.185.355.395.08
EV/EBIT Ratio
6.638.244.696.027.216.87
EV/FCF Ratio
--4.61-6.2221.40
Debt / Equity Ratio
0.630.630.570.510.420.33
Debt / EBITDA Ratio
5.695.693.553.592.452.25
Debt / FCF Ratio
--4.25-3.1210.44
Net Debt / Equity Ratio
0.230.230.220.230.050.06
Net Debt / EBITDA Ratio
2.092.091.461.810.320.42
Net Debt / FCF Ratio
--1.61-2.540.371.77
Asset Turnover
0.640.640.770.830.770.69
Inventory Turnover
5.285.286.657.897.104.93
Quick Ratio
0.760.760.870.920.901.00
Current Ratio
1.091.091.181.271.151.35
Return on Equity (ROE)
5.58%5.58%10.60%8.84%6.16%7.32%
Return on Assets (ROA)
2.83%2.83%4.23%3.78%4.05%3.61%
Return on Invested Capital (ROIC)
5.17%5.14%8.45%6.50%6.95%7.08%
Return on Capital Employed (ROCE)
7.40%7.40%10.30%9.00%11.10%9.60%
Earnings Yield
4.44%4.09%16.39%10.70%4.86%7.87%
FCF Yield
--37.36%-17.77%19.88%5.94%
Dividend Yield
6.34%-7.36%6.02%3.35%3.84%
Payout Ratio
148.37%-47.60%36.54%58.45%10.89%
Buyback Yield / Dilution
-2.03%-2.03%2.66%2.49%-0.04%1.29%
Total Shareholder Return
4.31%-2.03%10.02%8.51%3.32%5.12%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.